Global Footprint Harland Medical Systems operates across the United States, Ireland, Israel, and Costa Rica, enabling nearshore and regional support for medical device coatings. This global reach can shorten lead times, reduce logistics costs, and facilitate multi-site deployments for customers expanding internationally.

Coating Lifecycle End-to-end offering spanning coating solutions, equipment, testing, process development, services, and maintenance; design and development support leverages SOLIDWORKS and Minitab for robust processes and data-driven QA, enabling bundled offerings and long-term service contracts.

CTS1100 Opportunity The CTS1100 Coating Thickness Testing System launched in 2022 creates a cross-sell path to existing coating customers and new leads requiring precise thickness measurement and QA data. Pairing CTS1100 with coatings and testing services, plus training and maintenance, can drive incremental revenue and strengthen retention.

European Entry Opening a European headquarters in Cork, Ireland in 2022 signals a strong on-the-ground presence for European medical device makers. Targeted campaigns there can win regional coating projects, accelerate service agreements, and improve regulatory and QA support for EU customers.

Mid-market Focus With revenue in the 10-25 million range and 51-200 employees, Harland sits in the mid-market segment that often seeks comprehensive, vendor-managed coating solutions. This profile supports targeting mid-size OEMs and contract manufacturers that require multi-region support, end-to-end services, and scalable coating programs.